Crossmark

The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells

Crossref DOI link: https://doi.org/10.1007/s00281-025-01047-8

Published Online: 2025-04-03

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Novák, Julianna https://orcid.org/0009-0008-8291-0767
Takács, Tamás https://orcid.org/0000-0002-2665-7145
Tilajka, Álmos https://orcid.org/0009-0003-0333-6669
László, Loretta https://orcid.org/0000-0003-0367-4900
Oravecz, Orsolya https://orcid.org/0000-0002-7342-183X
Farkas, Emese https://orcid.org/0009-0000-4422-360X
Than, Nándor Gábor https://orcid.org/0000-0001-9385-7019
Buday, László https://orcid.org/0000-0003-3518-5757
Balogh, Andrea https://orcid.org/0000-0003-0322-1522
Vas, Virág https://orcid.org/0000-0001-7249-6816
Funding

Funding for this research was provided by:

HUN-REN Research Centre for Natural Sciences
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 11 July 2024

Accepted: 7 February 2025

First Online: 3 April 2025

Declarations

:

: The authors declare no conflict of interest.